
High-dose omega-3 raises AFib risk in high-CVD-risk people, not at low doses (2026)
Louis warns that the atrial fibrillation risk from high-dose omega-3 is real. A 2021 meta-analysis of 7 RCTs (81,210 people) found higher AF risk, and a 2026 meta-analysis of 35 RCTs (114,592 people) confirmed it at higher doses in people at high CVD risk, but not in those without high risk, and not at low doses in either group.
